DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,045,941 | -25.7% | 50,700 | +6.3% | 0.26% | -25.0% |
| Q2 2023 | $1,407,037 | +42.6% | 47,680 | +11.3% | 0.35% | +45.6% |
| Q1 2023 | $987,034 | +0.7% | 42,840 | +21.6% | 0.24% | +0.4% |
| Q4 2022 | $980,024 | +164.2% | 35,240 | +191.5% | 0.24% | +170.5% |
| Q3 2022 | $371,000 | -3.6% | 12,090 | -7.6% | 0.09% | -3.3% |
| Q2 2022 | $385,000 | – | 13,080 | +130700.0% | 0.09% | – |
| Q1 2022 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q4 2021 | $1,476,000 | +55.0% | 33,080 | +75.2% | 0.31% | +9.4% |
| Q3 2021 | $952,000 | -14.1% | 18,880 | +33.7% | 0.29% | -10.1% |
| Q2 2021 | $1,108,000 | +156.5% | 14,120 | +86.8% | 0.32% | +116.3% |
| Q1 2021 | $432,000 | -59.8% | 7,560 | -41.1% | 0.15% | -57.5% |
| Q4 2020 | $1,074,000 | -16.2% | 12,825 | -64.2% | 0.35% | -11.1% |
| Q3 2020 | $1,282,000 | +1.3% | 35,795 | -31.6% | 0.39% | +8.1% |
| Q2 2020 | $1,265,000 | +51.5% | 52,309 | +9.7% | 0.36% | +18.0% |
| Q1 2020 | $835,000 | +14.1% | 47,700 | +13.6% | 0.30% | +5.2% |
| Q4 2019 | $732,000 | +17.7% | 42,000 | +3.4% | 0.29% | +20.3% |
| Q3 2019 | $622,000 | +8.4% | 40,610 | +46.9% | 0.24% | -1.2% |
| Q2 2019 | $574,000 | -31.2% | 27,650 | -23.0% | 0.24% | -36.5% |
| Q1 2019 | $834,000 | +54.4% | 35,930 | +37.5% | 0.38% | +40.1% |
| Q4 2018 | $540,000 | -34.5% | 26,130 | -31.1% | 0.27% | -23.7% |
| Q3 2018 | $825,000 | – | 37,930 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |